About D.R.E.A.M.

D.R.E.A.M. is a 501(c)(3) non-profit organization that was founded in 2009 by the Kramer family of West Bloomfield, Michigan as a result of their first-hand experience with Type 1 diabetes. Founders, Peri and Evan Kramer, began their fight for a cure for diabetes after their son, Tyler, was diagnosed in 2005.  Since then, they have made it their personal mission to fight diabetes and work tirelessly to help their son and the millions of others affected by diabetes.

D.R.E.A.M.’s objective is to fund research and educational projects to discover a cure for diabetes. It merges Peri and Evan Kramer’s business experience and extensive fundraising efforts to direct research and support doctors and researchers, like those at the University of Michigan C.S. Mott Children’s Hospital.

Unfortunately, there are many more stories of families like the Kramer’s who have children diagnosed with diabetes. As of today, there is no known cure for Type 1 diabetes. Your support can help fund the research that is needed to find the cure!

 

CLICK HERE FOR INFORMATION ON UPCOMING EVENTS!

D.R.E.A.M.’s mission is to fund research and educational projects to discover a cure for diabetes. The Kramer's extensive fundraising efforts prior to forming D.R.E.A.M. planted the seed to direct research and support doctors and researchers, like those at the University of Michigan C.S. Mott Children’s Hospital.

 

IN HONOR OF NATIONAL DIABETES AWARENESS MONTH, NOVEMBER 2016, WE ARE PLEASED TO ANNOUNCE THE ROBERT W. CONSIDINE FOUNDATION HAS AWARDED D.R.E.A.M. A $250,000 GRANT TO PURCHASE TELEHEALTH LAPTOPS FOR THE UNIVERSITY OF MICHIGAN C.S. MOTT CHILDREN'S HOSPITAL!!!

The laptops will be provided by JEMS Telehealth, a medical device manufacturer of HIPAA compliant portable telehealth solutions for patient consults on mobile devices. This telemedicine equipment will enable the hospital to distribute the devices to children with Type 1 diabetes in rural areas of Michigan, where there is limited access to a pediatric endocrinologist. Telehealth communications allows patients to interact with a healthcare provider in a convenient manner for chronically ill patients. The hospital will collect data for this pilot study on the effect telehealth visits have on controlling blood sugars in children with Type 1 diabetes. It allows children to stay at home, visit with their healthcare provider, then quickly return to school or extra-curricular activities, and get on with their day.  As this technology is live-streamed from portable devices, communication can be performed anytime, and from virtually anywhere. This is especially ideal for newly diagnosed patients who are unfamiliar with how to manage diabetes, and in emergency situations.

"On behalf of the RW Considine foundation we are pleased to provide the initial funding for the purchase of the RONCON telehealth units, manufactured by JEMS Telehealth, to the D.R.E.A.M. Foundation.  We hope that this gift and the units it provides to children with type 1 diabetes and their families will find it easier to visit with their doctor or specialist from the comfort of their homes, without the burdens of expenses and time consumed for travel", Bob Boesiger, Board Member of the RW Considine Foundation. 

“We are so honored and excited to receive this grant,” said Tyler Kramer, Vice-President of D.R.E.A.M. “Thanks to the support from the RW Considine Foundation, we’re able to help children with type 1 diabetes throughout Michigan. Having had diabetes for over 10 years, I want to help other kids struggling with my same condition, especially kids living in remote areas who don’t have resources or access to their doctor. I’ve traveled across the country to help kids, and I’m excited to help even more children in Michigan.”

For children with Type 1 diabetes, patients need to see a pediatric endocrinologist for their care approximately 4 times a year; however, in Michigan only 46 pediatric endocrinologists are registered1. As a result, for patients in rural areas, access to such physicians can be complicated, expensive and time-consuming for children and their parents. “We are honored that JEMS is the selected platform to play a role in assisting families in better, more efficient health care,” stated Kevin Lasser, founder and CEO of JEMS Telehealth Technology.

"We are delighted to have the opportunity to work with D.R.E.A.M. and JEMS Telehealth to use technology to create new models of care delivery for our patients with type 1 diabetes." Joyce Lee, MD, MPH, Robert Kelch Professor of Pediatrics at the University of Michigan.

“Through D.R.E.A.M., we hope to make a difference in the lives of the children with type 1 diabetes.  We are honored to be able to make this donation to Mott Children’s Hospital. Tyler was a pediatric endocrinology patient at the hospital for many years, and always received excellent quality health care, which helped him manage his diabetes successfully, and make a smooth transition to adult diabetes healthcare,” D.R.E.A.M. President, Evan Kramer,

1. “Pediatric Endocrinologists” US News. U.S. News & World Report, n.d. Web. 07 Oct. 2016.

Read more about why the Kramer family is determined to raise money and fund research projects, in the hopes of finding a cure for diabetes.

The Kramer Story

 

Make a Donation to D.R.E.A.M.  

Honor someone you love or remember someone you miss with a Tribute to D.R.E.A.M.

 

 

Thank you for your support!

Peri and Evan Kramer